Vaccine proven to prevent cervical cancer

The results of a study of the HPV vaccine, Gardasil, have revealed that it is nearly 100 per cent effective against the two types of HPV responsible for most cases of cervical cancer.

Gardasil shown to be almost 100% effective
Gardasil shown to be almost 100% effective

Over 12,000 women between the ages of 15 and 26 years were randomised to receive three doses of either Gardasil or placebo. The primary composite endpoint was cervical intraepithelial neoplasia grade 2 or 3, adenocarcinoma in situ, or cervical cancer related to HPV-16 or HPV-18.

Vaccine efficacy for the prevention of the primary composite endpoint was 98 per cent.

The full paper can be found on the New England Journal of Medicine website.

What do you think? Comment below or email us at healthcare.republic@haymarket.com

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in